Last reviewed · How we verify
Chirocain (LEVOBUPIVACAINE)
Levobupivacaine (Chirocain), marketed by Purdue Pharma LP, is a local anesthetic primarily indicated for cesarean section anesthesia, competing in a well-established market with several same-class drugs. Its key strength lies in its mechanism of action, which effectively blocks sodium channels in nerve cells to prevent pain signals, offering a targeted solution for surgical anesthesia. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | LEVOBUPIVACAINE |
|---|---|
| Sponsor | Purdue Pharma Lp |
| Drug class | levobupivacaine |
| Target | Cytochrome P450 2D6 |
| Modality | Small molecule |
| Therapeutic area | Pain |
| Phase | FDA-approved |
| First approval | 1999 |
Approved indications
- Anesthesia for cesarean section
- Local anesthesia
- Major Nerve Block for Surgery
- Regional Anesthesia for Labor Pain
- Regional Anesthesia for Postoperative Pain
- Regional Anesthesia for Surgery
Common side effects
Key clinical trials
- Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty (NA)
- Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients (NA)
- Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer (PHASE2)
- Efficacy of Erector Spinae Plane Block in Major Video-assisted Thoracic Surgery Compared to Intrathecal Morphine and Intercostal Nerve Block.
- Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis (NA)
- Femoral Rami Obturator Nerve Trunk (FRONT) Block in Intramedullary Nail Surgery . (NA)
- Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
- Advantage of Tramadol in Local Analgesia Post-Sternotomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chirocain CI brief — competitive landscape report
- Chirocain updates RSS · CI watch RSS
- Purdue Pharma Lp portfolio CI